Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients

Fig. 2

Distribution of simulated plasma concentrations (median with 95% CI) across body surface area (BSA) quartiles for BSA-based, flat and stratified dosing. Dashed horizontal lines represent the desired threshold plasma concentrations (< 1 μmol/L at 42 h post-dose and < 0.3 μmol/L at 48 h post-dose). Description of doses under each regimen is presented in Table 4

Back to article page